Preclinical investigation of the antitumour effects of anti-CD19-idarubicin immunoconjugates (Q41540554)
scientific article published on August 1, 1993
Language:
(P31) (Q13442814)
(P304) 195-202
(P407) (Q1860)
(P433) 3
(P478) 37
(P577) Sunday, August 1, 1993
(P953) https://europepmc.org/articles/PMC11038212
https://europepmc.org/articles/PMC11038212?pdf=render
https://doi.org/10.1007/bf01525435
http://link.springer.com/article/10.1007/BF01525435/fulltext.html
http://link.springer.com/content/pdf/10.1007/BF01525435.pdf
http://link.springer.com/content/pdf/10.1007/BF01525435
(P1433) (Q5031409)
(P1476) "Preclinical investigation of the antitumour effects of anti-CD19-idarubicin immunoconjugates" (language: en)
(P2093) A. J. Rowland
G. A. Pietersz
I. F. McKenzie
(P2860) (Q39218339)
(Q33479733)
(Q68090182)
(Q68973456)
(Q41334006)
(Q68183386)
(Q52828546)
(Q54391719)
(Q33352919)
(Q68812235)
(Q40737523)
(Q67685133)
(Q68812167)
(Q70078986)
(Q67714030)
(Q40746210)
(Q69023454)
(Q68140254)
(Q70966489)
(Q39548934)
(Q41722400)
(Q43786477)
(Q35595959)
(Q25938984)
(Q37404033)
(Q68519005)
(Q45252963)
(Q38725006)
(Q69868005)
(Q69891840)
(Q69520763)
(Q68720076)
(Q67720709)
(Q69522036)
(Q38332089)
other details
description scientific article published on August 1, 1993

External Links